---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-014543"
form_type: "8-K"
ticker: "PRLD"
cik: "0001678660"
company_name: "Prelude Therapeutics Inc"
filed_at: "2025-02-05T23:59:59+00:00"
generated_at: "2026-05-27T02:45:15.782248+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Prelude Therapeutics appoints Bryant D. Lim as permanent CFO; base salary $483K

## Summary
- Bryant D. Lim, previously interim CFO, appointed permanent CFO effective Feb 3, 2025; retains roles of Chief Legal Officer and Corporate Secretary.
- Amended employment agreement provides base salary of $483,000, discretionary bonus up to 40% of base, and option for 200,000 shares vesting over 4 years.
- Severance: nine months of base salary for termination without cause (non-change-of-control); twelve months for termination without cause or good reason related to change of control.
- Option grant vests 25% on first anniversary and 1/48 monthly thereafter, subject to continued service.

## SEC filing metadata
- accession: 0000950170-25-014543
- form_type: 8-K
- ticker: PRLD
- cik: 0001678660
- company_name: Prelude Therapeutics Inc
- filed_at: 2025-02-05T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1678660/000095017025014543/0000950170-25-014543-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1678660/000095017025014543/prld-20250203.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-014543
- JSON: https://secwatch.observer/filing/0000950170-25-014543.json
- Plain text: https://secwatch.observer/filing/0000950170-25-014543.txt

## Key facts
- Executive change
  Bryant D. Lim was appointed as Chief Financial Officer at Prelude Therapeutics Inc.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On February 3, 2025 (the “Effective Date”), the Board approved the appointment of Mr. Lim as the Company’s permanent Chief Financial Officer, effective as of the Effective Date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1678660/000095017025014543/0000950170-25-014543-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.